| Literature DB >> 6796689 |
A Rosowsky, R Forsch, J Uren, M Wick.
Abstract
The gamma-tert-butyl ester (1), gamma-hydrazide (2), gamma-n-butylamide (3), and gamma-benzylamide (4) derivatives of methotrexate (MTX) were synthesized from 4-amino-4-deoxy-N10-methylpteroic acid (APA) and the appropriate blocked L-glutamic acid precursors with the aid of the peptide bond forming reagent diethyl phosphorocyanidate. The affinity of these side chain modified products for dihydrofolate reductase (DHFR) from Lactobacillus casei and L1210 mouse leukemic cells was determined spectrophotometrically or by competitive radioligand binding assay, and their cytotoxicity was evaluated against L1210 leukemic cells in culture. The results provide continuing support for the view that the "gamma-terminal region" of the MTX side chain is an attractive site for molecular modification of this anticancer agent.Entities:
Mesh:
Substances:
Year: 1981 PMID: 6796689 DOI: 10.1021/jm00144a016
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446